2006 Media Release 20 December 2006
Dosing Commenced in Phase IIa PBT2 Trial of Alzheimer's Patients 19 December 2006
Prana Co-Founding Scientist Receives Grand Hamdam International Award for Medical Services 6 December 2006
Prana Co-Founding Scientist Appointed Executive Director of MHRI 21 November 2006
Prana Raises A$7.8 Million to Fully Fund Phase IIa Clinical Trial of PBT2 in Patients with Alzheimer's Disease 1 November 2006
Prana to Present at the 8th Rodman & Renshaw Annual Healthcare Conference 16 October 2006
Prana Co-Founding Scientst to Receive International Prize for Excellence in Biomedical Research 13 October 2006
Prana Auditors Provide Going Concern Note 5 October 2006
Regulatory Approval to Start PBT2 Phase IIa Clinical Trial in Alzheimer's Disease Patients 28 September 2006
Prana Co-Founding Scientist Dr Rudolph Tanzi Seleceted as One of The Harvard 100 7 August 2006
Prana to Present at Banc of America 2006 Specialty Pharmaceuticals Conference 27 July 2006
Prana Co-Founding Scientist Receives Lifetime Achievement Award
in Alzheimer's Disease Research 24 July 2006
Prana Provides Additional Comment on PBT2 in Response to Recent Press
Coverage and Share Price Activity 20 July 2006
PBT2 Demonstrates Rapid and Potent Effects in Cognition, Reduction of Brain Soluble
Beta-amyloid and Significant Improvement in Synaptic Function in Mouse Models 18 July 2006
Prana Co-Founding Scientist to Present During Exciting Advancements in Alzheimer's Therapies Session
at ICAD in Madrid 12 May 2006
Confirmation of Conference Call Details 11 May 2006
PBT2 Phase IIa Clinical Trial in Alzheimer's Disease Patients 5 May 2006
Independent Report Received on PBT2 Phase I Clinical Trial 7 February 2006
PBT2 Successfully Completes Initial Phase I clinical Trial Program 1 February 2006
Aging Cell Paper Further Validates Prana Science
|
